Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ·Healthcare·Biotechnology
$8.23
+5.72%
Mkt Cap $119.71M
Analyst Ratings
Buy
7
Hold
0
Sell
0
Price Target (15 analysts)
$38.50
Range $33.00 – $44.00
Implied Upside
+368.1%
Consensus $38.50 vs current $8.23